# AS3MT

## Overview
The AS3MT gene encodes the enzyme arsenite methyltransferase, a critical component in the biotransformation of arsenic within the human body. This enzyme belongs to the class of methyltransferases and is primarily responsible for the methylation of arsenic, converting it into less toxic forms such as monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA), which are more easily excreted. The AS3MT protein is characterized by a SAM-dependent methyltransferase fold, featuring a Rossmann fold that facilitates its catalytic activity (Ajees2012Structure). Genetic variations in the AS3MT gene, including single nucleotide polymorphisms, can significantly influence the efficiency of arsenic metabolism, thereby affecting individual susceptibility to arsenic toxicity and related health conditions (Wood2006Human; Engström2011Polymorphisms). The enzyme's activity is not only crucial for detoxification processes but also plays a role in modulating immune responses through interactions with the NLRP3 inflammasome (Qiu2022AS3MT). Understanding the structure and function of AS3MT is essential for elucidating its role in arsenic detoxification and its implications for human health.

## Structure
The human AS3MT protein is an arsenic(III) S-adenosylmethionine methyltransferase involved in arsenic metabolism. Its primary structure consists of 375 amino acids, with several conserved cysteine residues crucial for its catalytic function, including Cys61, Cys156, and Cys206 (Ajees2012Structure). The secondary structure of AS3MT includes a composition of 29.0% α-helix, 23.9% β-pleated sheet, 17.9% β-turn, and 29.2% random coil (Song2009Structure–function). 

The tertiary structure of AS3MT features a SAM-dependent methyltransferase fold, characterized by a Rossmann fold, which is common in SAM-dependent methyltransferases (Ajees2012Structure). The enzyme's active site includes a binding pocket for arsenic and SAM, with cysteine residues playing a key role in catalysis (Ajees2012Structure). 

AS3MT functions as a monomer in solution, unlike many methyltransferases that are active in dimeric forms (Mersaoui2022Arsenic). The protein's structure is influenced by several single nucleotide polymorphisms (SNPs), such as R173W and M287T, which affect enzyme stability and arsenic metabolism (Ajees2012Structure). These structural features are essential for the enzyme's role in arsenic biotransformation.

## Function
The AS3MT gene encodes the enzyme arsenic (+3 oxidation state) methyltransferase, which is crucial for the methylation of arsenic in humans. This enzyme facilitates the conversion of inorganic arsenic into its methylated metabolites, monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA), which are less toxic and more readily excreted from the body (Engström2013Efficient; Fujihara2010Global). The methylation process is a key detoxification mechanism, reducing arsenic toxicity and its associated health risks (Wood2006Human).

AS3MT is primarily active in the liver, a major site for detoxification and excretion of arsenicals, but it is also expressed in other tissues such as the kidney, heart, and adrenal gland (YoshinagaSakurai2021Regulation). The enzyme uses S-adenosylmethionine (SAM) as a methyl donor to transfer methyl groups to arsenic, facilitating its conversion to less harmful forms (Chernoff2020Genetic).

Genetic variations in the AS3MT gene, such as single nucleotide polymorphisms (SNPs), can influence the efficiency of arsenic metabolism, leading to differences in arsenic detoxification among individuals and populations (Wood2006Human; Engström2011Polymorphisms). These variations can affect enzyme activity and protein expression levels, impacting the overall efficiency of arsenic clearance from the body (Wood2006Human).

## Clinical Significance
Mutations and polymorphisms in the AS3MT gene have been linked to various health conditions, particularly those related to arsenic exposure. Genetic variations in AS3MT can influence arsenic metabolism, affecting the risk of developing arsenic-related diseases such as cancer. For instance, certain AS3MT polymorphisms are associated with an increased risk of lung and bladder cancer in populations exposed to arsenic, as these variations can alter the proportions of arsenic metabolites in the body (de2017Associations). The rs11191439 polymorphism, in particular, has been linked to higher lung cancer risk, especially in individuals with high arsenic exposure (de2017Associations).

In addition to cancer, AS3MT polymorphisms have been associated with the risk of premalignant arsenic skin lesions. The Met287Thr variant, for example, is linked to a higher risk of developing these lesions, as it affects the balance of arsenic metabolites in the urine (Valenzuela2009Association). Furthermore, AS3MT genetic variations have been implicated in the risk of basal cell carcinoma, with certain haplotypes modifying arsenic metabolism and influencing susceptibility to this condition (Engström2014Genetic). These findings underscore the clinical significance of AS3MT in determining individual susceptibility to arsenic-related health effects.

## Interactions
AS3MT interacts with the NLRP3 inflammasome, promoting its activation during arsenic exposure. This interaction was confirmed through co-immunoprecipitation assays, which identified specific amino acid regions involved in the interaction: AS3MT (amino acids 201-375) binds to NLRP3 (amino acids 211-550). AS3MT also regulates NLRP3 expression via m6A methylation, affecting mRNA stability. Interference with AS3MT reduces m6A methylation content and blocks interactions between NLRP3 and m6A methylase, thereby reducing NLRP3 mRNA stability (Qiu2022AS3MT).

The enzyme's interaction with S-adenosylmethionine (SAM) is crucial for its methylation activity. The binding of SAM to AS3MT involves specific residues that contribute significantly to the binding free energy, with electrostatic interactions playing a dominant role. This interaction is essential for the enzyme's catalytic activity, as mutations in key residues can lead to a loss of function (Abro2016Binding).

AS3MT also undergoes automethylation on cysteine residues, a process enhanced by cofactors such as glutathione (GSH). This automethylation does not hinder its ability to methylate inorganic arsenic, indicating that AS3MT remains catalytically active post-automethylation (Mersaoui2022Arsenic).


## References


[1. (Valenzuela2009Association) Olga L. Valenzuela, Zuzana Drobná, Erika Hernández-Castellanos, Luz C. Sánchez-Peña, Gonzalo G. García-Vargas, Víctor H. Borja-Aburto, Miroslav Stýblo, and Luz M. Del Razo. Association of as3mt polymorphisms and the risk of premalignant arsenic skin lesions. Toxicology and Applied Pharmacology, 239(2):200–207, September 2009. URL: http://dx.doi.org/10.1016/j.taap.2009.06.007, doi:10.1016/j.taap.2009.06.007. This article has 102 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.taap.2009.06.007)

[2. (Chernoff2020Genetic) Meytal Chernoff, Lin Tong, Kathryn Demanelis, Donald Vander Griend, Habib Ahsan, and Brandon L Pierce. Genetic determinants of reduced arsenic metabolism efficiency in the 10q24.32 region are associated with reducedas3mtexpression in multiple human tissue types. Toxicological Sciences, 176(2):382–395, May 2020. URL: http://dx.doi.org/10.1093/toxsci/kfaa075, doi:10.1093/toxsci/kfaa075. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/toxsci/kfaa075)

[3. (Ajees2012Structure) A. Abdul Ajees, Kavitha Marapakala, Charles Packianathan, Banumathi Sankaran, and Barry P. Rosen. Structure of an as(iii) s-adenosylmethionine methyltransferase: insights into the mechanism of arsenic biotransformation. Biochemistry, 51(27):5476–5485, June 2012. URL: http://dx.doi.org/10.1021/bi3004632, doi:10.1021/bi3004632. This article has 110 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi3004632)

[4. (Fujihara2010Global) Junko Fujihara, Mikiko Soejima, Toshihiro Yasuda, Yoshiro Koda, Tetsuro Agusa, Takashi Kunito, Miki Tongu, Takaya Yamada, and Haruo Takeshita. Global analysis of genetic variation in human arsenic (+3 oxidation state) methyltransferase (as3mt). Toxicology and Applied Pharmacology, 243(3):292–299, March 2010. URL: http://dx.doi.org/10.1016/j.taap.2009.11.020, doi:10.1016/j.taap.2009.11.020. This article has 23 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.taap.2009.11.020)

[5. (Song2009Structure–function) Xiaoli Song, Zhirong Geng, Jingshu Zhu, Chengying Li, Xin Hu, Ningsheng Bian, Xinrong Zhang, and Zhilin Wang. Structure–function roles of four cysteine residues in the human arsenic (+3 oxidation state) methyltransferase (has3mt) by site-directed mutagenesis. Chemico-Biological Interactions, 179(2–3):321–328, May 2009. URL: http://dx.doi.org/10.1016/j.cbi.2008.12.018, doi:10.1016/j.cbi.2008.12.018. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cbi.2008.12.018)

[6. (de2017Associations) Rosemarie de la Rosa, Craig Steinmaus, Nicholas K. Akers, Lucia Conde, Catterina Ferreccio, David Kalman, Kevin R. Zhang, Christine F. Skibola, Allan H. Smith, Luoping Zhang, and Martyn T. Smith. Associations between arsenic (+3 oxidation state) methyltransferase (as3mt) and n‐6 adenine‐specific dna methyltransferase 1 (n6amt1) polymorphisms, arsenic metabolism, and cancer risk in a chilean population. Environmental and Molecular Mutagenesis, 58(6):411–422, June 2017. URL: http://dx.doi.org/10.1002/em.22104, doi:10.1002/em.22104. This article has 40 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/em.22104)

[7. (Engström2014Genetic) Karin S. Engström, Marie Vahter, Tony Fletcher, Giovanni Leonardi, Walter Goessler, Eugen Gurzau, Kvetoslava Koppova, Peter Rudnai, Rajiv Kumar, and Karin Broberg. Genetic variation in arsenic (+3 oxidation state) methyltransferase (as3mt), arsenic metabolism and risk of basal cell carcinoma in a <scp>e</scp>uropean population. Environmental and Molecular Mutagenesis, 56(1):60–69, August 2014. URL: http://dx.doi.org/10.1002/em.21896, doi:10.1002/em.21896. This article has 45 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/em.21896)

[8. (Mersaoui2022Arsenic) Sofiane Y. Mersaoui, Cynthia Guilbert, Hsiang Chou, Christelle Douillet, D. Scott Bohle, Miroslav Stýblo, Stéphane Richard, and Koren K. Mann. Arsenic 3 methyltransferase (as3mt) automethylates on cysteine residues in vitro. Archives of Toxicology, 96(5):1371–1386, March 2022. URL: http://dx.doi.org/10.1007/s00204-022-03248-8, doi:10.1007/s00204-022-03248-8. This article has 4 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00204-022-03248-8)

[9. (Qiu2022AS3MT) Tianming Qiu, Chenbing Wu, Xiaofeng Yao, Qiuyue Han, Ningning Wang, Weizhuo Yuan, Jingyuan Zhang, Yan Shi, Liping Jiang, Xiaofang Liu, Guang Yang, and Xiance Sun. As3mt facilitates nlrp3 inflammasome activation by m6a modification during arsenic-induced hepatic insulin resistance. Cell Biology and Toxicology, 39(5):2165–2181, February 2022. URL: http://dx.doi.org/10.1007/s10565-022-09703-7, doi:10.1007/s10565-022-09703-7. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10565-022-09703-7)

[10. (Wood2006Human) Thomas C. Wood, Oreste E. Salavagionne, Baidehi Mukherjee, Liewei Wang, Annette F. Klumpp, Bianca A. Thomae, Bruce W. Eckloff, Daniel J. Schaid, Eric D. Wieben, and Richard M. Weinshilboum. Human arsenic methyltransferase (as3mt) pharmacogenetics. Journal of Biological Chemistry, 281(11):7364–7373, March 2006. URL: http://dx.doi.org/10.1074/jbc.m512227200, doi:10.1074/jbc.m512227200. This article has 113 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m512227200)

[11. (YoshinagaSakurai2021Regulation) Kunie Yoshinaga-Sakurai, Toby G. Rossman, and Barry P. Rosen. Regulation of arsenic methylation: identification of the transcriptional region of the human as3mt gene. Cell Biology and Toxicology, 38(5):765–780, May 2021. URL: http://dx.doi.org/10.1007/s10565-021-09611-2, doi:10.1007/s10565-021-09611-2. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10565-021-09611-2)

[12. (Abro2016Binding) Asma Abro and Syed Sikander Azam. Binding free energy based analysis of arsenic (+ 3 oxidation state) methyltransferase with s-adenosylmethionine. Journal of Molecular Liquids, 220:375–382, August 2016. URL: http://dx.doi.org/10.1016/j.molliq.2016.04.109, doi:10.1016/j.molliq.2016.04.109. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.molliq.2016.04.109)

[13. (Engström2013Efficient) Karin S. Engström, Mohammad Bakhtiar Hossain, Martin Lauss, Sultan Ahmed, Rubhana Raqib, Marie Vahter, and Karin Broberg. Efficient arsenic metabolism — the as3mt haplotype is associated with dna methylation and expression of multiple genes around as3mt. PLoS ONE, 8(1):e53732, January 2013. URL: http://dx.doi.org/10.1371/journal.pone.0053732, doi:10.1371/journal.pone.0053732. This article has 61 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0053732)

[14. (Engström2011Polymorphisms) Karin Engström, Marie Vahter, Simona Jurkovic Mlakar, Gabriela Concha, Barbro Nermell, Rubhana Raqib, Alejandro Cardozo, and Karin Broberg. Polymorphisms in arsenic(+iii oxidation state) methyltransferase ( as3mt ) predict gene expression of as3mt as well as arsenic metabolism. Environmental Health Perspectives, 119(2):182–188, February 2011. URL: http://dx.doi.org/10.1289/ehp.1002471, doi:10.1289/ehp.1002471. This article has 145 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1289/ehp.1002471)